Emergent BioSolutions Inc. (0IGA)
LSE
6.79
-0.02 (-0.37%)
Closed
Sep 28, 2026
Day's Range
6.646.81
52 wk Range
4.3713.91
Financial Statements - 0IGA - Emergent BioSolutions Inc.
Revenue
198.87M▼ 12.9%
Net Income
15.99M▼ 60.6%Net Margin 8.0%
EBITDA
54.11M▼ 41.3%
Free Cash Flow
21.12M▼ 71.6%
Income Statement
| Period Ending | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|
| Sales | 198.87M | 228.39M | 189.33M | 154.57M |
| Cost of Goods | 21.14M | 25.33M | 23.92M | 25.37M |
| Gross Profit | 177.72M | 203.05M | 165.41M | 129.20M |
 Operating Expense | - | - | - | - |
| Operating Income | 19M | 82.08M | 68.22M | 43.45M |
| Non-Operating Interest | - | - | - | - |
| Other Income Expense | -4.63M | -28.91M | -3.72M | -26.12M |
| Pre Tax Income | 23.07M | 47.46M | 52.28M | 980.32K |
| Income Tax | 7.08M | 6.83M | 11.74M | -27.60M |
| Net Income | 15.99M | 40.63M | 40.54M | 28.58M |
| EPS Basic | 0.023777 | 0.062728 | 0.06497 | 0.0469 |
| EPS Diluted | 0.021512 | 0.059038 | 0.060489 | 0.043468 |
| Basic Shares Outstanding | 642.28M | 636.26M | 626.31M | 606.61M |
| Diluted Shares Outstanding | 642.28M | 636.26M | 626.31M | 606.61M |
| Ebit | - | - | - | - |
| Ebitda | 54.11M | 92.11M | 75.41M | 50.98M |
| Net Income Continuous Operations | 23.07M | 47.46M | 68.22M | 43.45M |
| Minority Interests | - | - | - | - |
| Preferred Stock Dividends | - | - | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
